Kenvue Inc. (BMV:KVUE)

Mexico flag Mexico · Delayed Price · Currency is MXN
308.11
-1.89 (-0.61%)
At close: Dec 5, 2025
-29.85%
Market Cap 590.12B
Revenue (ttm) 275.44B
Net Income (ttm) 26.30B
Shares Out n/a
EPS (ttm) 13.72
PE Ratio 22.44
Forward PE 15.62
Dividend 15.85 (5.05%)
Ex-Dividend Date Nov 12, 2025
Volume 7,810
Average Volume 748
Open 310.00
Previous Close 310.00
Day's Range 308.11 - 310.00
52-Week Range 259.01 - 439.23
Beta n/a
RSI 51.97
Earnings Date Nov 6, 2025

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other... [Read more]

Industry Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2022
Employees 22,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol KVUE
Full Company Profile

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD Financial Statements

News

There is no news available yet.